Article
Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
Journal of computer-aided molecular design - 1 Jan 2020
Hanpaibool Chonnikan, Leelawiwat Matina, Takahashi Kaito, Rungrotmongkol Thanyada
Abstract excerpt
Influenza epidemics are responsible for an average of 3-5 millions of severe cases and up to 500,000 deaths around the world. One of flu pandemic types is influenza A(H1N1)pdm09 virus (pdm09H1N1). Oseltamivir is the antiviral drug used to treat influenza targeting at neuraminidase (NA) located on the viral surface. Influenza virus undergoes high mutation rates and leads to drug resistance, and thus the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
